ROYAL BANK OF CANADA - SIGILON THERAPEUTICS INC ownership

SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 53 filers reported holding SIGILON THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SIGILON THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$9,000
-40.0%
18,203
+1.1%
0.00%
Q2 2022$15,000
-46.4%
18,001
-8.3%
0.00%
Q1 2022$28,000
-53.3%
19,634
-8.8%
0.00%
Q4 2021$60,000
+400.0%
21,537
+937.9%
0.00%
Q3 2021$12,000
+71.4%
2,075
+200.7%
0.00%
Q2 2021$7,000
-74.1%
690
-43.6%
0.00%
Q1 2021$27,0001,2240.00%
Other shareholders
SIGILON THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 10,370,369$8,608,0000.32%
HARBOURVEST PARTNERS LLC 740,740$615,0000.20%
SOUNDMARK WEALTH MANAGEMENT, LLC 25,555$21,0000.02%
Artal Group S.A. 276,000$229,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 150,000$125,0000.00%
Choate Investment Advisors 66,666$55,0000.00%
CANADA PENSION PLAN INVESTMENT BOARD 1,485,185$1,233,0000.00%
Ergoteles LLC 71,555$59,0000.00%
TWO SIGMA SECURITIES, LLC 17,837$15,0000.00%
STATE OF WISCONSIN INVESTMENT BOARD 509,629$423,0000.00%
View complete list of SIGILON THERAPEUTICS INC shareholders